ISRCTN81821807
Completed
N/A
Clinical assessment of a new catheter surface coating with antimicrobial properties: safety - handling - efficacy
Gambro Corporate Research (Germany)0 sites100 target enrollmentMarch 24, 2006
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- End-stage renal disease patients with need for a temporary hemodialysis catheter
- Sponsor
- Gambro Corporate Research (Germany)
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Need for renal replacement therapy
- •2\. Age \=18 years
- •3\. Written informed consent
Exclusion Criteria
- •1\. Known acute hepatitis B virus (HBV), hepatitis C virus (HCV) or human immunodeficiency virus (HIV)
- •2\. Age \>75 years
- •3\. Any infection associated wtih one or more positive blood cultures within 10 days prior to planned implantation
- •4\. Any bacteremia associated with a previous catheter
- •5\. Known pregnancy
- •6\. Hospitalisation for more than 14 days
- •7\. Respiratory assist
- •8\. Use of antibiotics
- •9\. Participation in another study during the preceding 30 days
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Clinical assessment of a new catheter surface coating with antimicrobial properties: efficacy and effect of intensive catheter and exit site care educatioRenal diseaseUrological and Genital DiseasesISRCTN93939200Gambro Dialysatoren GmbH (Germany)180
Completed
N/A
Clinical Assessment of a New Catheter Surface Coating With Antimicrobial PropertiesRenal InsufficiencyNCT00621712Vantive Health LLC90
Completed
N/A
Safety and Performance of a New Coating for Urinary Intermittent CathetersIntermittent Urethral CatheterizationNCT01800903Coloplast A/S40
Completed
N/A
A clinical evaluation of new catheter for continuous peripheral nerve blockosteoarthritisJPRN-UMIN000019630Department of Anesthesiology , Wakayama medical school40
Recruiting
N/A
Exploratory Investigation on a Novel CatheterNL-OMON53534Wellspect HealthCare15